CDK1 and pulmonary arterial hypertension: The expression of CDC2 in PAH HPASMC was greatly abolished by both pharmacological inhibition with thiostrepton blocking FOXM1 expression and volasertib blocking PLK1 expression (Figure 2C) and siRNAs knocking down expression of FOXM1 and PLK1 (Figure 3A).